
AMN Stock Forecast & Price Target
AMN Analyst Ratings
Bulls say
AMN Healthcare Services reported 2Q25 revenue of $658.2 million, which, despite being an 11% year-over-year decline, surpassed both internal estimates and consensus expectations. The company's gross margin improved to 29.8%, exceeding its guidance range, and reflecting a sequential increase of 120 basis points. Additionally, AMN has demonstrated a consistent ability to outperform expectations, with an average revenue surprise of 3% and an EBITDA surprise of 12% over the past four quarters, contributing to a positive outlook for the stock.
Bears say
AMN Healthcare Services Inc reported a significant decline in segment revenues, with the nurse and allied solutions segment experiencing a 9% year-over-year decrease, and the physician and leadership solutions segment reflecting a substantial 14% decline year-over-year. The overall operating margin also contracted, declining by 30 basis points quarter-over-quarter to 7.5%, raising concerns about profitability. Additionally, a notable 31% year-over-year drop in Vendor Management System (VMS) revenue further underscores challenges within the company’s core operations, despite a slight increase in language services revenue.
This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares